SERENA, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 2295
AS - Asia 320
EU - Europa 261
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2879
Nazione #
US - Stati Uniti d'America 2294
CN - Cina 289
FI - Finlandia 81
DE - Germania 69
SE - Svezia 46
IT - Italia 38
VN - Vietnam 23
UA - Ucraina 10
GB - Regno Unito 9
IN - India 5
NL - Olanda 3
FR - Francia 2
RU - Federazione Russa 2
CA - Canada 1
EU - Europa 1
KR - Corea 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SG - Singapore 1
ZA - Sudafrica 1
Totale 2879
Città #
Woodbridge 419
Fairfield 367
Houston 241
Ann Arbor 209
Wilmington 167
Cambridge 154
Seattle 136
Ashburn 109
Chandler 105
Princeton 74
Beijing 73
Nanjing 64
Jacksonville 62
Medford 53
San Diego 42
Des Moines 26
Jinan 26
Roxbury 26
Helsinki 25
Dong Ket 23
Padova 20
Shenyang 16
Guangzhou 14
Hebei 14
Nanchang 11
Changsha 10
Dearborn 10
Tianjin 10
Falls Church 7
Jiaxing 6
Norwalk 6
Nürnberg 6
Redwood City 6
Zhengzhou 6
Munich 5
Haikou 4
Ningbo 4
Hangzhou 3
Hefei 3
Indiana 3
Kunming 3
Lanzhou 3
Shanghai 3
Venezia 3
Fuzhou 2
Leawood 2
Redmond 2
Rockville 2
Taizhou 2
Torino 2
Alghero 1
Barcelos 1
Boardman 1
Borås 1
Costa Mesa 1
Ferrara 1
Los Angeles 1
Manila 1
Muizenberg 1
Murfreesboro 1
Orlando 1
Pinehaven 1
Shaoxing 1
Singapore 1
Taiyuan 1
Toronto 1
Wenzhou 1
Totale 2606
Nome #
Three-dimensional porous scaffold allows long-term wild-type cell delivery in dystrophic muscle 110
Confined 3D microenvironment regulates early differentiation in human pluripotent stem cells 99
Microfluidic-driven viral infection on cell cultures: Theoretical and experimental study 90
Production of arrays of cardiac and skeletal muscle myofibers by micropatterning techniques on a soft substrate 89
Microfluidic-driven viral infection on cell cultures: Theoretical and experimental study 88
High-efficiency cellular reprogramming with microfluidics 88
Micro-Arrayed Human Embryonic Stem Cells-Derived Cardiomyocytes for in vitro Functional Assay 87
Transcriptomic Characterization of a Human In Vitro Model of Arrhythmogenic Cardiomyopathy Under Topological and Mechanical Stimuli 85
Production of arrays of cardiac and skeletal muscle myofibers by micropatterning techniques on a soft substrate 84
Soft substrates drive optimal differentiation of human healthy and dystrophic myotubes 81
Enhancement of viability of muscle precursor cells on 3D scaffold in a perfusion bioreactor 80
Microfluidic-assisted cyclic mechanical stimulation affects cellular membrane integrity in a human muscular dystrophy in vitro model 77
Microfluidic-assisted cyclic mechanical stimulation affects cellular membrane integrity in a human muscular dystrophy in vitro model 76
Electrical stimulation of human embryonic stem cells: Cardiac differentiation and the generation of reactive oxygen species. 75
Single-cell PCR analysis of murine embryonic stem cells cultured on different substrates highlights heterogeneous expression of stem cell markers 72
Electrophysiologic stimulation improves myogenic potential of muscle precursor cells grown in a 3D collagen scaffold 68
Human-on-chip for therapy development and fundamental science 68
Substrate and mechanotransduction influence SERCA2a localization in human pluripotent stem cell-derived cardiomyocytes affecting functional performance 65
Analysis of calcium transients and uniaxial contraction force in single human embryonic stem cell-derived cardiomyocytes on microstructured elastic substrate with spatially controlled surface chemistries 62
Microtechnology for stem cell culture 58
Culture of satellite cells in an electrically-stimulated three-dimensional scaffold for the generation of skeletal muscle engineered graft 56
Single-cell PCR analysis of murine embryonic stem cells cultured on different substrates highlights heterogeneous expression of stem cell markers 56
Reversible alteration of calcium dynamics in cardiomyocytes during acute hypoxia transient in a microfluidic platform. 52
A microfluidic platform for the spatial-temporal generation of infarcted heart conditions: highthroughput screening on human Embryonic Stem Cells-derived cardiomyocytes 51
Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne Muscular Dystrophy patient-derived cardiomyocytes. 51
Controlled cardiac differentiation of human embryonic stem cell-derived embryoid bodies in scalable bioreactors 50
Skeletal muscle differentiation on a chip shows human donor mesoangioblasts’ efficiency in restoring dystrophin in a duchenne muscular dystrophy model 50
An in vitro model for cardiac cell therapy: coupling a microfluidic platform with arrayed human embryonic stem cells-derived cardiomyocytes for screening pathological conditions 44
ENGINEERING A 3D IN VITRO MODEL OF HUMAN SKELETAL MUSCLE 43
Engineering an in vitro model of human muscle dystrophy for highthroughput screenings and development of therapeutic strategies 42
Alteration of calcium dynamics in murine cardiomyocytes during acute hypoxia 38
Substrate-driven maturation of human pluripotent stem cell-derived cardiomyocytes 37
An in vitro model for cardiac cell therapy: coupling a microfluidic platform with arrayedhuman embryonic stem cells-derived cardiomyocytes for screening pathological conditions 37
Microfluidic-driven processes enhance control and optimization of adenoviral infection efficiency on cell cultures 37
Dystrophin expression restoration by human artificial chromosome in cardiomyocytes-derived from DMD patient hiPS cells 37
Cyclic mechanical stretch affects membrane integrity during myogenesis 35
Microscale in vitro model for screening pathological conditions on human embryonic stem cell-derived cardiomyocytes 35
Mesoangioblasts contribution to dystrophin restoration in a human in vitro model 35
Muscle tissue micro engineering 35
Culture of Human Embryonic Stem Cell-derived Embryoid Bodies in multiscale bioreactors for optimal control of cardiac differentiation 34
Microscale in vitro technologies for screening pathological conditions on human embryonic stem cells-derived cardiomyocytes: an in vitro model for cardiac cell therapy 32
A microfluidic platform for the spatial-temporal generation of infarcted heart conditions: highthroughput screening on human Embryonic Stem Cells-derived cardiomyocytes 31
hESC-CM maturation is driven by the cell-substrate interaction 31
Highthroughput microfluidic platform to enhance adenoviral vector-mediated transgene expression 30
Effects of electrical stimulation on ROS expression of human embryonic stem cell 28
Dystrophin restoration in mdx mice transplanted with wt satellite cells 28
Controlled cardiac differentiation of human embryonic stem cell-derived embryoid bodies in scalable bioreactors 23
One-step high-throughput reprogramming and differentiation on a chip 22
Microfluidic cell-stretching device for mechano-transduction studies 20
Micropatterning topology on soft substrates affects myoblasts proliferation and differentiation 19
One-step high-throughput reprogramming and differentiation on a chip 18
Culture of satellite cells in electrical stimulated 3D collagen scaffold for the creation of skeletal-muscle engineered graft 17
Complete genetic correction of cardiomyocytes from dystrophic patient-derived human induced pluripotent stem cells 16
Production of arrays of cardiac organoids and skeletal muscle fibers by micropatterning techniques 16
The role of mechanotransduction in human pluripotent stem cell derived-cardiomyocytes 15
MYOD modified mRNA drives direct on-chip programming of human pluripotent stem cells into skeletal myocytes 15
Engineering an in vitro model of human muscle dystrophy for highthroughput screenings and development of therapeutic strategies 14
Engineering microfluidic-technologies for culturing human embryonic stem cells 13
Microenvironment design for the development of an in vitro model of Human Duchenne Muscular Dystrophy 13
Engineering microfluidics for mimicking stem cells microenvironment 12
In vitro engineering of muscle precursor cell niche by mimicking multiple stimuli 12
Engineering the cell culture microenvironment for in vitro model development 9
Microscale Tissue Engineering of human skeletal and cardiac muscles for in vitro applications 5
Totale 2896
Categoria #
all - tutte 4001
article - articoli 2494
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 107
Totale 6602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201866 0014 010 11 43411
2018/2019294 04144 91 315 25710184
2019/2020732 13019243 7047 6174 701514619
2020/2021371 1428843 2219 2423 53464744
2021/2022599 131205934 2035 3062 25842151
2022/2023218 11494100 00 00 0000
Totale 2896